- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 387
Stratasys to print up to $100m for Origin
Stanford University has scored an exit after photosensitive polymer-based 3D printing business Origin agreed to a $100m acquisition.
Dec 14, 2020AbCellera accomplishes $483m initial public offering
The Eli Lilly-backed antibody discovery platform developer's shares opened at more than three times their IPO price to net it a valuation topping $15bn.
Dec 14, 2020Stratasys locates Origin for $100m acquisition
TDK Ventures has scored an exit after 3D printing technology developer Origin after Stratasys agreed to buy it in a deal that could reach $100m.
Dec 14, 2020DataRobot updates series F to $320m
Snowflake, Hewlett Packard Enterprise and Salesforce Ventures helped the enterprise AI platform developer hit a $2.8bn valuation.
Dec 14, 2020Uber drives $75m Joby Aviation investment
The ride hailing service has sold its Uber Elevate subsidiary to urban aircraft developer and portfolio company Joby alongside a new $75m investment.
Dec 14, 2020Calm coalesces $75m into series C round
This latest funding round for the CAA-backed meditation app developer doubled its valuation to $2bn and brought its total funding to $217m.
Dec 14, 2020Corporate venturing deal net: 7-11 December 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Dec 11, 2020Daily deal net: December 11, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Dec 11, 2020Squire squares $59m series C round
SoftBank Opportunity Fund has backed a debt and equity round that reportedly valued the hair appointment management platform at $250m.
Dec 11, 2020Tempus amps up funding with $200m
Google and existing investor Novo contributed to a series G2 round valuing the precision medicine developer at $8.1bn post-money.
Dec 11, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


